Raft endocytosis of AMF regulates mitochondrial dynamics through Rac1 signaling and the Gp78 ubiquitin ligase

Journal of Cell Science

Volumn 126, Issue 15, 2013, Pages 3295-3304

  Shankar, Jay ^a   Kojic, Liliana D ^a   St Pierre, Pascal ^a   Wang, Peter T C ^a   Fu, Min ^a   Joshi, Bharat ^a   Nabi, Ivan R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

AMF; Gp78; Mitochondrial fission; Mitofusin; Rac1; Raft dependent endocytosis; Ubiquitin ligase

Indexed keywords

CELL SURFACE RECEPTOR; DYNAMIN; GLUCOSE 6 PHOSPHATE ISOMERASE; GP78 UBIQUITIN LIGASE; MITOFUSIN 1; MITOFUSIN 2; PHOSPHATIDYLINOSITOL 3 KINASE; RAC1 PROTEIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ARTICLE; CAVEOLA; CELL STRAIN COS7; CONTROLLED STUDY; DOWN REGULATION; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; FLOW CYTOMETRY; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; HUMAN; HUMAN CELL; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL VOLUME; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; WILD TYPE;

AMF; GP78; MITOCHONDRIAL FISSION; MITOFUSIN; RAC1; RAFT-DEPENDENT ENDOCYTOSIS; UBIQUITIN LIGASE;

BREAST NEOPLASMS; CELL LINE, TUMOR; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM-ASSOCIATED DEGRADATION; FIBROSARCOMA; GLUCOSE-6-PHOSPHATE ISOMERASE; HUMANS; MITOCHONDRIA; RAC1 GTP-BINDING PROTEIN; RECEPTORS, AUTOCRINE MOTILITY FACTOR; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84883444103     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.120162     Document Type: Article

References (61)

1. Benlimame, N., Le, P. U. and Nabi, I. R. (1998). Localization of autocrine motility factor receptor to caveolae and clathrin-independent internalization of its ligand to smooth endoplasmic reticulum. Mol. Biol. Cell 9, 1773-1786.
2. Chiu, C. G., St-Pierre, P., Nabi, I. R. and Wiseman, S. M. (2008). Autocrine motility factor receptor: a clinical review. Expert Rev. Anticancer Ther. 8, 207-217.
3. Christianson, J. C., Olzmann, J. A., Shaler, T. A., Sowa, M. E., Bennett, E. J., Richter, C. M., Tyler, R. E., Greenblatt, E. J., Harper, J. W. and Kopito, R. R. (2011). Defining human ERAD networks through an integrative mapping strategy. Nat. Cell Biol. 14, 93-105.
4. Ewers, H., Romer, W., Smith, A. E., Bacia, K., Dmitrieff, S., Chai, W., Mancini, R., Kartenbeck, J., Chambon, V., Berland, L. et al. (2010). GM1 structure determines SV40-induced membrane invagination and infection. Nat. Cell Biol. 12, 11-18.
5. Fairbank, M., St-Pierre, P. and Nabi, I. R. (2009). The complex biology of autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and its receptor, the gp78/AMFR E3 ubiquitin ligase. Mol. Biosyst. 5, 793-801.
6. Fang, S., Ferrone, M., Yang, C., Jensen, J. P., Tiwari, S. and Weissman, A. M. (2001). The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum. Proc. Natl. Acad. Sci. USA 98, 14422-14427.
7. Friedman, J. R., Lackner, L. L., West, M., DiBenedetto, J. R., Nunnari, J. and Voeltz, G. K. (2011). ER tubules mark sites of mitochondrial division. Science 334, 358-362.
8. Fu, M., Li, L., Albrecht, T., Johnson, J. D., Kojic, L. D. and Nabi, I. R. (2011). Autocrine motility factor/phosphoglucose isomerase regulates ER stress and cell death through control of ER calcium release. Cell Death Differ. 18, 1057-1070.
9. Fu, M., St-Pierre, P., Shankar, J., Wang, P. T. C., Joshi, B. and Nabi, I. R. (2013). Regulation of mitophagy by the Gp78 E3 ubiquitin ligase. Mol. Biol. Cell 24, 1153-1162.
10. Funasaka, T. and Raz, A. (2007). The role of autocrine motility factor in tumor and tumor microenvironment. Cancer Metastasis Rev. 26, 725-735.
11. Funasaka, T., Hogan, V. and Raz, A. (2009). Phosphoglucose isomerase/autocrine motility factor mediates epithelial and mesenchymal phenotype conversions in breast cancer. Cancer Res. 69, 5349-5356.
12. Goetz, J. G., Genty, H., St-Pierre, P., Dang, T., Joshi, B., Sauvé, R., Vogl, W. and Nabi, I. R. (2007). Reversible interactions between smooth domains of the endoplasmic reticulum and mitochondria are regulated by physiological cytosolic Ca2+ levels. J. Cell Sci. 120, 3553-3564.
13. Haga, A., Funasaka, T., Niinaka, Y., Raz, A. and Nagase, H. (2003). Autocrine motility factor signaling induces tumor apoptotic resistance by regulations Apaf-1 and Caspase-9 apoptosome expression. Int. J. Cancer 107, 707-714.
14. Hebert, D. N., Bernasconi, R. and Molinari, M. (2010). ERAD substrates: which way out? Semin. Cell Dev. Biol. 21, 526-532.
15. Joffre, C., Barrow, R., Ménard, L., Calleja, V., Hart, I. R. and Kermorgant, S. (2011). A direct role for Met endocytosis in tumorigenesis. Nat. Cell Biol. 13, 827-837.
16. Joshi, B., Li, L. and Nabi, I. R. (2010). A role for KAI1 in promotion of cell proliferation and mammary gland hyperplasia by the gp78 ubiquitin ligase. J. Biol. Chem. 285, 8830-8839.
17. Kanbe, K., Chigira, M. and Watanabe, H. (1994). Effects of protein kinase inhibitors on the cell motility stimulated by autocrine motility factor. Biochim. Biophys. Acta 1222, 395-399.
18. Khandelwal, P., Ruiz, W. G. and Apodaca, G. (2010). Compensatory endocytosis in bladder umbrella cells occurs through an integrin-regulated and RhoA- and dynamin-dependent pathway. EMBO J. 29, 1961-1975.
19. Kojic, L. D., Joshi, B., Lajoie, P., Le, P. U., Cox, M. E., Turbin, D. A., Wiseman, S. M. and Nabi, I. R. (2007). Raft-dependent endocytosis of autocrine motility factor is phosphatidylinositol 3-kinase-dependent in breast carcinoma cells. J. Biol. Chem. 282, 29305-29313.
20. Kojic, L. D., Wiseman, S. M., Ghaidi, F., Joshi, B., Nedev, H. N., Saragovi, H. U. and Nabi, I. R. (2008). Raft-dependent endocytosis of autocrine motility factor/phosphoglucose isomerase: a potential drug delivery route for tumor cells. PLoS ONE 3, e3597.
21. Lajoie, P. and Nabi, I. R. (2010). Lipid rafts, caveolae, and their endocytosis. Int. Rev. Cell Mol. Biol. 282, 135-163.
22. Lamaze, C., Dujeancourt, A., Baba, T., Lo, C. G., Benmerah, A. and Dautry-Varsat, A. (2001). Interleukin 2 receptors and detergent-resistant membrane domains define a clathrin-independent endocytic pathway. Mol. Cell 7, 661-671.
23. Le, P. U. and Nabi, I. R. (2003). Distinct caveolae-mediated endocytic pathways target the Golgi apparatus and the endoplasmic reticulum. J. Cell Sci. 116, 1059-1071.
24. Le, P. U., Guay, G., Altschuler, Y. and Nabi, I. R. (2002). Caveolin-1 is a negative regulator of caveolae-mediated endocytosis to the endoplasmic reticulum. J. Biol. Chem. 277, 3371-3379.
25. Le Roy, C. and Wrana, J. L. (2005). Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat. Rev. Mol. Cell Biol. 6, 112-126.
26. Lee, J. N., Song, B., DeBose-Boyd, R. A. and Ye, J. (2006). Sterol-regulated degradation of Insig-1 mediated by the membrane-bound ubiquitin ligase gp78. J. Biol. Chem. 281, 39308-39315.
27. Li, E., Stupack, D., Bokoch, G. M. and Nemerow, G. R. (1998). Adenovirus endocytosis requires actin cytoskeleton reorganization mediated by Rho family GTPases. J. Virol. 72, 8806-8812.
28. Liang, J. S., Kim, T., Fang, S., Yamaguchi, J., Weissman, A. M., Fisher, E. A. and Ginsberg, H. N. (2003). Overexpression of the tumor autocrine motility factor receptor Gp78, a ubiquitin protein ligase, results in increased ubiquitinylation and decreased secretion of apolipoprotein B100 in HepG2 cells. J. Biol. Chem. 278, 23984-23988.
29. Lingwood, D. and Simons, K. (2010). Lipid rafts as a membrane-organizing principle. Science 327, 46-50.
30. Liu, T.-F., Tang, J.-J., Li, P.-S., Shen, Y., Li, J.-G., Miao, H.-H., Li, B.-L. and Song, B.-L. (2012). Ablation of gp78 in liver improves hyperlipidemia and insulin resistance by inhibiting SREBP to decrease lipid biosynthesis. Cell Metab. 16, 213-225.
31. Macia, E., Ehrlich, M., Massol, R., Boucrot, E., Brunner, C. and Kirchhausen, T. (2006). Dynasore, a cell-permeable inhibitor of dynamin. Dev. Cell 10, 839-850.
32. Mondal, S., Ghosh-Roy, S., Loison, F., Li, Y., Jia, Y., Harris, C., Williams, D. A. and Luo, H. R. (2011). PTEN negatively regulates engulfment of apoptotic cells by modulating activation of Rac GTPase. J. Immunol. 187, 5783-5794.
33. Morito, D., Hirao, K., Oda, Y., Hosokawa, N., Tokunaga, F., Cyr, D. M., Tanaka, K., Iwai, K. and Nagata, K. (2008). Gp78 cooperates with RMA1 in endoplasmic reticulum-associated degradation of CFTRDeltaF508. Mol. Biol. Cell 19, 1328-1336.
34. Nabi, I. R. and Raz, A. (1987). Cell shape modulation alters glycosylation of a metastatic melanoma cell-surface antigen. Int. J. Cancer 40, 396-402.
35. Nabi, I. R. and Raz, A. (1988). Loss of metastatic responsiveness to cell shape modulation in a newly characterized B16 melanoma adhesive cell variant. Cancer Res. 48, 1258-1264.
36. Nabi, I. R., Watanabe, H. and Raz, A. (1990). Identification of B16-F1 melanoma autocrine motility-like factor receptor. Cancer Res. 50, 409-414.
37. Nonnenmacher, M. and Weber, T. (2011). Adeno-associated virus 2 infection requires endocytosis through the CLIC/GEEC pathway. Cell Host Microbe 10, 563-576.
38. Polo, S. and Di Fiore, P. P. (2006). Endocytosis conducts the cell signaling orchestra. Cell 124, 897-900.
39. Prosser, D. C., Drivas, T. G., Maldonado-Báez, L. and Wendland, B. (2011). Existence of a novel clathrin-independent endocytic pathway in yeast that depends on Rho1 and formin. J. Cell Biol. 195, 657-671.
40. Römer, W., Berland, L., Chambon, V., Gaus, K., Windschiegl, B., Tenza, D., Aly, M. R., Fraisier, V., Florent, J. C., Perrais, D. et al. (2007). Shiga toxin induces tubular membrane invaginations for its uptake into cells. Nature 450, 670-675.
41. Sabharanjak, S., Sharma, P., Parton, R. G. and Mayor, S. (2002). GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42-regulated, clathrin-independent pinocytic pathway. Dev. Cell 2, 411-423.
42. Sandvig, K., Pust, S., Skotland, T. and van Deurs, B. (2011). Clathrin-independent endocytosis: mechanisms and function. Curr. Opin. Cell Biol. 23, 413-420.
43. Sanlioglu, S., Benson, P. K., Yang, J., Atkinson, E. M., Reynolds, T. and Engelhardt, J. F. (2000). Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation. J. Virol. 74, 9184-9196.
44. Shen, Y., Kawamura, I., Nomura, T., Tsuchiya, K., Hara, H., Dewamitta, S. R., Sakai, S., Qu, H., Daim, S., Yamamoto, T. et al. (2010). Toll-like receptor 2- and MyD88-dependent phosphatidylinositol 3-kinase and Rac1 activation facilitates the phagocytosis of Listeria monocytogenes by murine macrophages. Infect. Immun. 78, 2857-2867.
45. Shimizu, K., Tani, M., Watanabe, H., Nagamachi, Y., Niinaka, Y., Shiroishi, T., Ohwada, S., Raz, A. and Yokota, J. (1999). The autocrine motility factor receptor gene encodes a novel type of seven transmembrane protein. FEBS Lett. 456, 295-300.
46. Silletti, S., Watanabe, H., Hogan, V., Nabi, I. R. and Raz, A. (1991). Purification of B16-F1 melanoma autocrine motility factor and its receptor. Cancer Res. 51, 3507-3511.
47. Silletti, S., Paku, S. and Raz, A. (1996). Tumor autocrine motility factor responses are mediated through cell contact and focal adhesion rearrangement in the absence of new tyrosine phosphorylation in metastatic cells. Am. J. Pathol. 148, 1649-1660.
48. Smith, M. H., Ploegh, H. L. and Weissman, J. S. (2011). Road to ruin: targeting proteins for degradation in the endoplasmic reticulum. Science 334, 1086-1090.
49. Song, B. L., Sever, N. and DeBose-Boyd, R. A. (2005). Gp78, a membrane-anchored ubiquitin ligase, associates with Insig-1 and couples sterol-regulated ubiquitination to degradation of HMG CoA reductase. Mol. Cell 19, 829-840.
50. St-Pierre, P., Dang, T., Joshi, B. and Nabi, I. R. (2012). Peripheral endoplasmic reticulum localization of gp78 ubiquitin ligase activity. J. Cell Sci. 125, 1727-1737.
51. Tsai, Y. C., Mendoza, A., Mariano, J. M., Zhou, M., Kostova, Z., Chen, B., Veenstra, T., Hewitt, S. M., Helman, L. J., Khanna, C. et al. (2007). The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation. Nat. Med. 13, 1504-1509.
52. Tsutsumi, S., Gupta, S. K., Hogan, V., Collard, J. G. and Raz, A. (2002). Activation of small GTPase Rho is required for autocrine motility factor signaling. Cancer Res. 62, 4484-4490.
53. Tsutsumi, S., Hogan, V., Nabi, I. R. and Raz, A. (2003). Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts. Cancer Res. 63, 242-249.
54. Tsutsumi, S., Yanagawa, T., Shimura, T., Kuwano, H. and Raz, A. (2004). Autocrine motility factor signaling enhances pancreatic cancer metastasis. Clin. Cancer Res. 10, 7775-7784.
55. Vembar, S. S. and Brodsky, J. L. (2008). One step at a time: endoplasmic reticulum-associated degradation. Nat. Rev. Mol. Cell Biol. 9, 944-957.
56. Wang, H.-J., Guay, G., Pogan, L., Sauvé, R. and Nabi, I. R. (2000). Calcium regulates the association between mitochondria and a smooth subdomain of the endoplasmic reticulum. J. Cell Biol. 150, 1489-1498.
57. Wang, Y., Nakayama, M., Pitulescu, M. E., Schmidt, T. S., Bochenek, M. L., Sakakibara, A., Adams, S., Davy, A., Deutsch, U., Lüthi, U. et al. (2010). Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465, 483-486.
58. Watanabe, H., Takehana, K., Date, M., Shinozaki, T. and Raz, A. (1996). Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide. Cancer Res. 56, 2960-2963.
59. Yanagawa, T., Watanabe, H., Takeuchi, T., Fujimoto, S., Kurihara, H. and Takagishi, K. (2004). Overexpression of autocrine motility factor in metastatic tumor cells: possible association with augmented expression of KIF3A and GDI-beta. Lab. Invest. 84, 513-522.
60. Yoshida, S., Hoppe, A. D., Araki, N. and Swanson, J. A. (2009). Sequential signaling in plasma-membrane domains during macropinosome formation in macrophages. J. Cell Sci. 122, 3250-3261.
61. Zhong, X., Shen, Y., Ballar, P., Apostolou, A., Agami, R. and Fang, S. (2004). AAA ATPase p97/valosin-containing protein interacts with gp78, a ubiquitin ligase for endoplasmic reticulum-associated degradation. J. Biol. Chem. 279, 45676-45684.